Change in MYCN-driven cell state opens therapeutic window in high-risk neuroblastoma

A switch between cell states within MYCN-amplified neuroblastoma promotes KDM4, inhibition of which shows promising anticancer potential.

New study seeks hereditary causes of childhood cancer

Prediabetes in Childhood Cancer Survivors Ups Cardiovascular, CKD Risks

Besponsa ‘More Effective’ at Driving Remission for Pediatric B-ALL

Cancer-predisposition variants associated with adverse outcomes in rhabdomyosarcoma

Researchers turn back the clock on cancer cells to offer new treatment paradigm

Study successfully mimics complex neuroblastoma vasculature on a chip to explore treatments

Longer exclusive breastfeeding may lower risk for childhood hematologic cancers

Predicting Infection Risk in Childhood Cancer

Researchers find genetic variant contributing to disparities in childhood leukemia risk

Chemotherapy cured my cancer. Years later it likely gave me heart disease.